The role of the E-cadherin/catenin complex in gastrointestinal cancer

Acta Gastro-Enterologica Belgica

Volumn 62, Issue 4, 1999, Pages 393-402

  Debruyne, P ^a   Vermeulen, S ^a   Mareel, M ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cancer; Catenins; E cadherin; Gastrointestinal; Invasion

Indexed keywords

BETA CATENIN; CARRIER PROTEIN; CATENIN; CELL DNA; UVOMORULIN;

CANCER INHIBITION; CARCINOGENESIS; CELL ADHESION; CELL COMMUNICATION; COMPLEX FORMATION; DIGESTIVE SYSTEM CANCER; DNA METHYLATION; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; REVIEW; TUMOR SUPPRESSOR GENE;

BETA CATENIN; CADHERINS; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; GASTROINTESTINAL NEOPLASMS; HUMANS; MUTATION; NEOPLASM INVASIVENESS; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0033388712     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (115)

1. KINZLER K.W., VOGELSTEIN B. Lessons from hereditary colorectal cancer. Cell, 1996, 87 : 159-170.
2. LENGAUER C., KINZLER K.W., VOGELSTEIN B. Genetic instability in colorectal cancers. Nature, 1997, 386 : 623-627.
3. MAREEL M., VERMEULEN S., BRACKE M. Moleculaire mechanismen van kankeruitzaaiing : adhesie moleculen en netwerken van signaaltransductie. Verh. K. Acad. Geneeskd. Belg., 1997, LIX nr. 4 : 327-351.
4. BRACKE M.E., VAN ROY F.M., MAREEL M.M. The E-cadherin/ catenin complex in invasion and metastasis. In : U. GÜNTHERT, W. BIRCHMEIER (eds). Attempts to Understand Metastasis Formation I, Springer, Berlin, 1996, 123-161.
5. MAREEL M., BERX G., VAN ROY F., BRACKE M. Cadherin/catenin complex : a target for antiinvasive therapy ? J. Cell. Biochem., 1996, 61 : 524-530.
6. ctn catenin gene (CTNNDI) : expression of multiple alternatively spliced isoforms. Genomics, 1998, 50 : 129-146.
7. BARTH A.I.M., NÄTHKE I.S., NELSON W.J. Cadherins, catenins and APC protein : interplay between cytoskeletal complexes and signaling pathways. Curr. Opin. Cell Biol. 1997, 9 : 683-690.
8. TAKEICHI M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science, 1991, 251 : 1451-1455.
9. MBALAVIELE G., CHEN H., BOYCE B.F., MUNDY G.R., YONEDA T. The role of cadherin in the generation of multinucleated osteoclasts from mononuclear precursors in murine marrow. J. Clin. Invest., 1995, 95 : 2757-2765.
10. LEE M.G., SHARROW S.O., FARR A.G., SINGER A., UDEY M.C. Expression of the homotypic adhesion molecule E-cadherin by immature murine thymocytes and thymic epithelial cells. J. Immunol., 1994, 152 : 5653-5659.
11. TANG A., AMAGAI M., GRANGER L.G., STANLEY J.R., UDEY M.C. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature, 1993, 361 : 82-85.
12. TANG A., ELLER M.S., HARA M., YAAR M., HIROHASHI S., GILCHREST B.A. E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J. Cell Sci., 1994, 107 : 983-992.
13. CEPEK K.L., SHAW S.K., PARKER C.M., RUSSELL G.J., MORROW J.S., RIMM D.L., BRENNER M.B. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the αEβ7 integrin. Nature, 1994, 372 : 190-193.
14. TROLLMO C., NILSSON I.-M., SOLLERMAN C., TARKOWSKI A. Expression of the mucosal lymphocyte integrin αEβ7 and its ligand E-cadherin in the synovium of patients with rheumatoid arthritis. Scand. J. Immunol., 1996, 44 : 293-298.
15. +CTL. J. Immunol., 1997, 159 : 3748-3756.
16. KRONELD U., JONSSON R., CARLSTEN H., BREMELL T., JOHANNESSEN A.C., TARKOWSKI A. Expression of the mucosal lymphocyte integrin αEβ7 and its ligand E-cadherin in salivary glands of patients with Sjögren's syndrome. Scand. J. Rheumatol., 1998, 27 : 215-218.
17. MENGAUD J., OHAYON H., GOUNON P., MÈGE R.-M., COSSART P. E-cadherin is the receptor for internalin, a surface protein required for entry of L. monocytogenes into epithelial cells. Cell, 1996, 84 : 923-932.
18. FANNON A.M., SHERMAN D.L., ILYINA-GRAGEROVA G., BROPHY P.J., FRIEDRICH V.L.JR., COLMAN D.R. Novel E-cadherin-mediated adhesion in peripheral nerve : Schwann cell architecture is stabilized by autotypic adherens junctions. J. Cell Biol., 1995, 129 : 189-202.
19. COUTIFARlS C., KAO L.-C. SEHDEV H.M., CHIN U., BABALOLA G.O., BLASCHUK O.W., STRAUSS III J.F. E-cadherin expression during the differentiation of human trophoblasts. Development, 1991, 113 : 767-777.
20. DANEN E.H., DE VRIES T.J., MORANDINI R., GHANEM G.G., RUITER D.J., VAN MUIJEN G.N. E-cadherin expression in human melanoma. Melanoma Res., 1996, 6 : 127-131.
21. BEHRENS J., MAREEL M.M., VAN ROY F.M., BIRCHMEIER W. Dissecting tumor cell invasion : epithelial cells acquire invasive properties following the loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol., 1989, 108 : 2435-2447.
22. VLEMINCKX K., VAKAET E. JR, MAREEL M., FIERS W., VAN ROY F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 1991, 66 : 107-119.
23. FRIXEN U.H., BEHRENS J., SACHS M., EBERLE G., VOSS B., WARDA A., LÖCHNER D., BIRCHMEIER W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol., 1991, 113: 173-185.
24. PERL A.-K., WILGENBUS P., DAHL U., SEMB H., CHRISTOFORI G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature, 1998, 392 : 190-193.
25. CHEN H., PARADIES N.E., FEDOR-CHAIKEN M., BRACKEN-BURY R. E-cadherin mediates adhesion and suppresses cell motility via distinct mechanisms. J. Cell Sci., 1997, 110 : 345-356.
26. BRACKE M.E., DEPYPERE H., LABIT C., VAN MARCK V., VENNEKENS K., VERMEULEN S.J., MAELFAIT I., PHILIPPÉ J., SERREYN R., MAREEL M.M. Functional downregulation of the E-cadherin/catenin complex leads to loss of contact inhibition of motility and of mitochondrial activity, but not of growth in confluent epithelial cell cultures. Eur. J. Cell Biol., 1997, 74 : 342-349.
27. YAMASHIRO S., YAMAKITA Y., ONO S., MATSUMURA F. Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells. Mol. Biol. Cell, 1998, 9 : 993-1006.
28. TAO Y.S., EDWARDS R.A., TUBB B., WANG S., BRYAN J., MCCREA PD. β-Catenin associates with the actin-bundling protein fascin in a noncadherin complex. J. Cell Biol., 1996, 134: 1271-1281.
29. HORDIJK P.L., TEN KLOOSTER J.P., VAN DER KAMMEN R.A., MICHIELS F. OOMEN L.C.J.M., COLLARD J.G. Inhibition of invasion of epithelial cells by Tiam1-Rac signaling. Science, 1997, 278 : 1464-1466.
30. TAKAISHI K., SASAKI T., KOTANI H., NISHIOKA H., TAKAI Y. Regulation of cell-cell adhesion by Rac and Rho small G proteins in MDCK cells. J. Cell Biol., 1997, 139 : 1047-1059.
31. OTTO T., BIRCHMEIER W., SCHMIDT U., HINKE A., SCHIPPER J., RÜBBEN H., RAZ A. Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas. Cancer Res., 1994, 54 : 3120-3123.
32. KEIRSEBILCK A., BONNÉ S., BRUYNEEL E., VERMASSEN P., LUKANIDIN E., MAREEL M., VAN ROY F. E-cadherin and metastasin (mts-1/S100A4) expression levels are inversely regulated in two tumor cell families. Cancer Res., 1998, 58 : 4587-4591.
33. VERMEULEN S.J., BRUYNEEL E.A., BRACKE M.E., DE BRUYNE G.K., VENNEKENS K.M., VLEMINCKX K.L., BERX G.J., VAN ROY F.M., MAREEL M.M. Transition from the noninvasive to the invasive phenotype and loss of α-catenin in human colon cancer cells. Cancer Res., 1995, 55 : 4722-4728.
34. VERMEULEN S.J., NOLLET F., TEUGELS E., VENNEKENS K.M., MALFAIT F., PHILIPPÉ J., SPELEMAN F., BRACKE M.E., VAN ROY F.M., MAREEL M.M. The αE-catenin gene (CTNNA1) acts as an invasion-suppressor gene in human colon cancer cells. Oncogene, 1999, 17: 905-915.
35. 2+-dependent cell-cell adhesion. Cell Adhesion Commun., 1993, 1 : 239-250.
36. BULLIONS L.C., NOTTERMAN D.A., CHUNG L.S., LEVINE A.J. Expression of wild-type α-catenin protein in cells with a mutant alpha-catenin gene restores both growth regulation and tumor suppressor activities. Mol. Cell. Biol., 1997, 17 : 4501-4508.
37. HART M.J., DE LOS SANTOS R., ALBERT I.N., RUBINFELD B., POLAKIS P. Downregulation of β-catenin by human Axin and its associatoion with the APC tumor suppressor. β-catenin and GSK3 β. Curr. Biol., 1998, 8 : 573-581.
38. BULLIONS L.C., LEVINE A.J. The role of beta-catenin in cell adhesion, signal transduction, and cancer. Curr. Opin. Oncol., 1998, 10 : 81-87.
39. SIMCHA I., SHTUTMAN I., SALOMON D., ZHURINSKY J., SADOT E., GEIGER B., BEN-ZE'EV A. Differential nuclear translocation and transactivation potential of β-catenin and plakoglobin. J. Cell Biol., 1998, 141 : 1433-1448.
40. HERMISTON M.L., WONG M.H., GORDON J.I. Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system. Genes Dev., 1996, 10 : 985-996.
41. BECKER K.-F., ATKINSON M.J., REICH U., BECKER I., NEKARDA H., SIEWERT J.R., HÖFLER H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res., 1994, 54 : 3845-3852.
42. BERX G., CLETON-JANSEN A.-M., STRUMANE K., DE LEEUW W.J.F., NOLLET F., VAN ROY F., CORNELISSE C. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Ocongene, 1996, 13 : 1919-1925.
43. ILYAS M., TOMLINSON I.P.M., HANBY A., TALBOT I.C., BODMER W.F. Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers. Gut, 1997, 40 : 654-659.
44. VERMEULEN S., VAN MARCK V., VAN HOORDE L., VAN ROY F., BRACKE M., MAREEL M. Regulation of the invasion suppressor function of the cadherin/catenin complex. Pathol. Res. Pract., 1996, 192 : 694-707.
45. YOSHIURA K., KANAI Y., OCHIAI A., SHIMOYAMA Y., SUGIMURA T., HIROHASHI S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl. Acad. Sci. USA, 1995, 92 : 7416-7419.
46. BEHRENS J., VAKAET L., FRIIS R., WINTERHAGER E., VAN ROY F., MAREEL M.M., BIRCHMEIER W. Loss of epithelial morphotype and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-src gene. J. Cell Biol., 1993, 120 : 757-766.
47. VLEMINCKX K.L., DEMAN J.J., BRUYNEEL E.A., VANDENBOSSCHE G.M.R., KEIRSEBILCK A.A., MAREEL M.M., VAN ROY F.M. Enlarged cell-associated proteoglycans abolish E-cadherin functionality in invasive tumor cells. Cancer Res., 1994, 54 : 873-877.
48. NOË V., CHASTRE E., BRUYNEEL E., GESPACH C. MAREEL M. Extracellular regulation of cancer invasion : the E-cadherin/catenin and other pathways. Biochem. Soc. Symp., 1999, 65 : 43-62.
49. NOË V., WILLEMS J., VANDEKERCKHOVE J., VAN ROY F., BRUYNEEL E., MAREEL M. Inhibition of adhesion and induction of epithelial cell invasion by HAV-containing E-cadherin-specific peptides. J. Cell Sci., 1999, 112 : 127-135.
50. BRACKE M.E., VYNCKE B.M., BRUYNEEL E.A., VERMEULEN S.J., DE BRUYNE G.K., VAN LAREBEKE N.A., VLEMINCKX K., VAN ROY F.M., MAREEL M.M. Insulin-like growth factor I activates the invasion suppressor function of E-cadherin in MCF-7 human mammary carcinoma cells in vitro. Br. J. Cancer, 1993, 68 : 282-289.
51. HISCOX S., HALLETT M.B., PUNTIS M.C.A., JIANG W.G. Inhibition of cancer cell motility and invasion by interleukin-12. Clin. Exp. Metastasis, 1995, 13 : 396-404.
52. SACCHI T.B., BANI D., BRANDI M.L., FALCHETTI A., BIGAZZI M. Relaxin influences growth, differentiation and cell-cell adhesion of human breast-cancer cells in culture. Int. J. Cancer, 1994, 57 : 129-134.
53. HINCK E., NELSON W.J., PAPKOFF J. Wnt-1 modulates cell-cell adhesion in mammalian cells by stabilizing β-catenin binding to the cell adhesion protein cadherin. J. Cell Biol., 1994, 124 : 729-741.
54. MACCALMAN C.D., FAROOKHI R., BLASCHUK O.W. Estradiol regulates E-cadherin mRNA levels in the surface epithelium of the mouse ovary. Clin. Exp. Metastasis, 1994, 12 : 276-282.
55. BRACKE M.E., CHARLIER C., BRUYNEEL E.A., LABIT C., MAREEL M.M., CASTRONOVO V. Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype. Cancer Res., 1994, 54 : 4607-4609.
56. CARRUBA G., MICELI D., D'AMICO D., FARRUGGIO R., COMITO L., MONTESANTI A., POLITO E., CASTAGNETTA L.A.M. Sex steroids up-regulate E-cadherin expression in hormone-responsive LNCaP human prostate cancer cells. Biochem. Biophys. Res. Commun., 1995, 212 : 624-631.
57. FUJIMOTO J., ICHIGO S., HORI M., MORISHITA S., TAMAYA T. Progestins and danazol effect on cell-to-cell adhesion, and E-cadherin and α- and β-catenin mRNA expressions. J. Steroid Biochem. Mol. Biol., 1996, 57 : 275-282.
58. VERMEULEN S.J., BRUYNEEL E.A., VAN ROY F.M., MAREEL M.M., BRACKE M.E. Activation of the E-cadherin/catenin complex in human MCF-7 breast cancer cells by all-trans-retinoic acid. Br. J. Cancer, 1995, 72 : 1447-1453.
59. JIANG W.G., HISCOX S., HALLETT M.B., HORROBIN D.F., MANSEL, R.E., PUNTIS M.C.A. Regulation of the expression of E-cadherin on human cancer cells by gamma-linolenic acid (GLA). Cancer Res., 1995, 55 : 5043-5048.
60. JIANG W.G., HISCOX S., HORROBIN D.F., HALLETT M.B., MANSEL R.E., PUNTIS M.C.A. Expression of catenins in human cancer cells and its regulation by n-6 polyunsaturated fatty acids. Anticancer Res., 1995, 15 : 2569-2574.
61. REVILLION F., VANDEWALLE B., HORNEZ L., FEFEBVRE J. Influence of cAMP on E-cadherin expression and cell surface heparan sulfate proteoglycan synthesis in human breast cancer cells. Anticancer Res., 1993, 13 : 1625-1629.
62. AKIMOTO T., MITSUHASHI N., SAITO Y., EBARA T., NIIBE H. Effect of radiation on the expression of E-cadherin and α-catenin and invasive capacity in human lung cancer cell line in vitro. Int. J. Radiat. Oncol. Biol Phys., 1998, 41 : 1171-1176.
63. ECKERT K., FUHRMANN-SELTER T., MAURER H.R. Docetaxel enhances the expression of E-cadherin and carcinoembryonic antigen (CEA) on human colon cancer cell lines in vitro. Anticancer Res., 1997, 17 : 7-12.
64. GRAFF J.R., HERMAN J.G., LAPIDUS R.G., CHOPRA H., XU R., JARRARD D.F., ISAACS W.B., PITHA P.M., DAVIDSON N.E., BAYLIN S.B. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res., 1995, 55 : 5195-5199.
65. BRACKE M.E., BRUYNEEL E.A., VERMEULEN S.J., VENNEKENS K., VAN MARCK V., MAREEL M.M. Citrus flavonoid effect on tumor invasion and metastasis. Food Technology, 1994, 48 : 121-124.
66. GUILFORD P., HOPKINS J., HARRAWAY J., MCLEOD M., MCLEOD N., HARAWIRA P., TAITE H., SCOULAR R., MILLER A., REEVE A.E. E-cadherin germline mutations in familial gastric cancer. Nature, 1998, 392 : 402-405.
67. GAYTHER S.A., GORRINGE K.L., RAMUS S.J., HUNTSMAN D., ROVIELLO F., GREHAN N., MACHADO J.C., PINTO E., SERUCA R., HALLING K., MACLEOD P., POWELL S.M., JACKSON C.E., PONDER B.A.J., CALDAS C. Identification of germ-line E-cadherin mutations in gastric cancer families of european origin. Cancer Res., 1998, 58 : 4086-4089.
68. KANAI Y., USHIJIMA S., HUI A.-M., OCHIAI A., TSUDA H., SAKAMOTO M., HIROHASHI S. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int. J. Cancer. 1997, 71 : 355-359.
69. ASHIDA K., TERADA T., KITAMURA Y., KAIBARA N. Expression of E-cadherin, α-catenin, β-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma : an immunohistochemical study. Hepatology, 1998, 27 : 974-982.
70. KOZYRAKI R., SCOAZEC J.-Y., FLEJOU J.-F., D'ERRICO A., BEDOSSA P., TERRIS B., FIORENTINO M., BRINGUIER A.-F., GRIGIONI W.F., FELDMANN G. Expression of cadherins and α-catenin in primary epithelial tumors of the liver. Gastroenterology, 1996, 110: 1137-1149.
71. DORUDI S., SHEFFIELD J.P., POULSOM R., NORT-HOVER J.M.A., HART I.R. E-cadherin expression in colorectal cancer. Am. J. Pathol., 1993, 142 : 981-986.
72. DORUDI S., HANBY A.M., POULSOM R., NORTHOVER J., HART I.R. Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome. Br. J. Cancer, 1995, 71 : 614-616.
73. GHADIMI B.M., BEHRENS J., BIRCHMEIER W., SCHLAG P.M. Foss of expression of E-cadherin, α-, β-, and γ-catenin in colorectal cancer. Clin. Exp. Metastasis, 1996, 14 (Suppl. 1) : 94-.
74. KINSELLA A.R., GREEN B., LEPTS G.C., HILL C.L., BOWIE G., TAYLOR B.A. The role of the cell-cell adhesion molecule E-cadherin in large bowel tumour cell invasion and metastasis. Br. J. Cancer, 1993, 67 : 904-909.
75. NIGAM A. K., SAVAGE F.J., BOULOS P.B., STAMP G.W., LIU D., PIGNATELLI M. Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br. J. Cancer, 1993, 68 : 507-514.
76. SHIOZAKI H., IIHARA K., OKA H., KADOWAKI T., MATSUI S., GOFUKU J., INOUE M., NAGAFUCHI A., TSUKITA S., MORI T. Immunohistochemical detection of α-catenin expression in human cancers. Am. J. Pathol, 1994, 144 : 667-674.
77. TAKAYAMA T., SHIOZAKI H., SHIBAMOTO S., OKA H., KIMURA Y., TAMURA S., INOUE M., MONDEN T., ITO F., MONDEN M. β-catenin expression in human cancers. Am. J. Pathol. 1996, 148 : 39-46.
78. VAN AKEN J., CUVELIER C.A., DE WEVER N., GAO Y., MAREEL M.M., ROELS H.J. Immunohistochemical analysis of E-cadherin expression in human colorectal tumours. Pathol. Res. Pract., 1993, 189 : 975-978.
79. VAN DER WURFF A.A.M., TEN KATE J., VAN DER LINDEN E.P.M., DINJENS W.N.M., ARENDS J.-W., BOSMAN F.T. L-Cam expression in normal, premalignant, and malignant colon mucosa. J. Pathol., 1992, 168 : 287-291.
80. MOHRI Y. Prognostic significance of E-cadherin expressin in human colorectal cancer tissue. Surg. Today, 1997, 27 : 606-612.
81. TAKAYAMA T., SHIOZAKI H., DOKI Y., OKA H., INOUE M., YAMAMOTO M., TAMURA S., SHIBAMOTO S., ITO F. MONDEN M. Aberrant expression and phosphorylation of β-catenin in human colorectal cancer. Br. J. Cancer, 1998, 77 : 605-61.1.
82. RAFTOPOULOS I., DAVARIS P., KARATZAS G., KARAYANNACOS P., KOURAKLIS G. Level of α-catenin expression in coloreclal cancer correlates with invasiveness, metastatic potential, and survival. J. Surg. Oncol., 1998, 68 : 92-99.
83. VAN DER WURFF A.A.M., VERMEULEN S.J.T., VAN DER LINDEN E.P.M., MAREEL M.M., BOSMAN F.T., ARENDS J.-W. Patterns of α- and β-catenin and E-cadherin expression in colorectal adenomas and carcinomas. J. Pathol., 1997, 182 : 325-330.
84. SKOUDY A., GOMEZ S., FABRE M., GARCIA DE HERREROS A. P120-catenin expression in human colorectal cancer. Int. J. Cancer, 1996, 68 : 14-20.
85. HISCOX S,. JIANG W.G. Expression of E-cadherin, α, β and γ-catenin in human colorectal cancer. Anticancer Rex., 1997, 17 : 1349-1354.
86. BONGIORNO P.F., AL-KASSPOOLES M., LEE S.W., RACHWAL W.J., MOORE J.H., WHYTE R.I., ORRINGER M.B., BEER D.G. E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus. Br. J. Cancer, 1995, 71 : 166-172.
87. KADOWAKI T., SHIOZAKI H., INOUE M., TAMURA S., OKA H., DOKI Y., IIHARA K., MATSUI S., IWAZAWA T., NAGAFUCHI A., TSUKITA S., MORI T. E-cadherin and α-catenin expression in human esophageal cancer. Cancer Res., 1994, 54 : 291-296.
88. SHIOZAKI H.,TAHARA H., OKA H., MIYATA M., KOBAYASHI K., TAMURA S., IIHARA K., DOKI Y., HIRANO S., TAKEICHI M., MORI T. Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am. J. Pathol., 1991, 139 : 17-23.
89. NAKANISHI Y., OCHIAI A., AKIMOTO S., KATO H., WATANABE H., TACHIMORI Y., YAMAMOTO S., HIROHASHI S. Expressin of E-cadherin, α-catenin, β-catenin and plakoglobin in esophageal carcinomas and its prognostic significance : immunohistochemical analysis of 96 lesions. Oncology, 1997, 54 : 158-165.
90. KRISHNADATH K.K., TILANUS H.W., VAN BLANKENSTEIN M., HOP W.C.J., KREMERS E.D., DINJENS W.N.M., BOSMAN F.T. Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. J. Pathol., 1997, 182 : 331-338.
91. SCOAZEC J.-Y., FLEJOU J.-F., D'ERRICO A., FIORENTINO M., ZAMPARELLI A., BRINGUIER A.-F., FELDMANN G., GRIGIONI W.F. Fibrolamellar carcinoma of the liver : composition of the extracellular matrix and expression of cell-matrix and cell-cell adhesion molecules. Hepalology, 1996, 24 : 1128-1136.
92. DE LA COSTE A., ROMAGNOLO B., BILLUART P., RENARD C.-A., BUENDIA M.-A., SOUBRANE O., FABRE M., CHELLY J., BELDJORD C., KAHN A., PERRET C. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA, 1998, 95 : 8847-8851.
93. GARCIA S., MARTINI F., DE MICCO C., ANDRAC L., SAPPA P., HARDWIGSEN J., LAVAUT M.-N., LE TREUT Y.-P., CHARPIN C. Valeur pronostique de l'expression de l'E-cadhérine dans les hépatocarcinomes. Ann. Pathol., 1998, 18 : 98-102.
94. IHARA A., KOIZUMI H., HASHIZUME R., UCHIKOSHI T. Expression of epithelial cadherin and α- and β-catenins in nontumoral livers and hepatocellular carcinomas. Hepatology, 1996, 23 : 1441-1447.
95. PIGNATELLI M., ANSARI T.W., GUNTER P., LIU D., HIRANO S., TAKFICHI M., KLOPPEL G., LEMOINE N.R. Loss of membranous E-cadherin expression in pancreatic cancer : correlation with lymph node metastasis, high grade, and advanced stage. J. Pathol., 1994, 174 : 243-248.
96. GUNJI N., ODA T., TODOROKI T., KANAZAWA N., KAWAMOTO T., YUZAWA K., SCARPA A., FUKAO K. Pancreatic carcinoma. Correlation between E-cadherin and α-catenin expression status and liver metastasis. Cancer, 1998, 82 : 1649-1656.
97. MUTA H., NOGUCHI M., KANAI Y., OCHIAI A., NAWATA H., HIROHASHI S. E-cadherin gene mutations in signet ring cell carcinoma of the stomach. Jpn. J. Cancer Res., 1996, 87 : 843-848.
98. CAI J.C., JIANG S.J., CHEN Z.P. Relationship between E-cadherin and growth pattern of gastric cancer and degree of cell differentiation. Chung hua Ping Li Hsueh Tsa Chih, 1994, 23 : 132-134.
99. MATSUI S., SHIOZAKI H., INOUE M., TAMURA S., DOKI Y., KADOWAKI T., IWAZAWA T., SHIMAYA K., NAGAFUCHI A., TSUKITA S., ET AL. Immunohistochemical evaluation of α-catenin expression in human gastric cancer. Virchows Arch., 1994, 424 : 375-381.
100. MATSUURA K., KAWANISHI J., FUJII S., IMAMURA M., HIRANO S., TAKEICHI M., NIITSU Y. Altered expression of E-cadherin in gastric cancer tissues and carcinomatous fluid. Br. J. Cancer, 1992, 66 : 1122-1130.
101. MAYER B., JOHNSON J.P., LEITL F., JAUCH K.W., HEISS M.M., SCHILDBERG F.W., BIRCHMEIER W., FUNKE I. E-cadherin expression in primary and metastatic gastric cancer : down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res., 1993, 53 : 1690-1695.
102. OCHIAI A., AKIMOTO S., SHIMOYAMA Y., NAGAFUCHI A., SHOICHIRO T., HIROHASHI S. Frequent loss of α-catenin expression in scirrhous carcinomas with scattered cell growth. Jpn. J. Cancer Res., 1994, 85 : 266-273.
103. OKA H., SHIOZAKI H., KOBAYASHI K., TAHARA H., TAMURA S., MIYATA M., DOKI Y., IIHARA K., MATSUYOSHI N., HIRANO S., TAKEICHI M., MORI T. Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer. Virchows Arch. A Pathol. Anat., 1992, 421 : 149-156.
104. SHINO Y., WATANABE A., YAMADA Y., TANASE M., YAMADA T., MATSUDA M., YAMASHITA J., TATSUMI M., MIWA T., NAKANO H. Clinicopathologic evaluation of immunohistochemical E-cadherin expression in human gastric carcinomas. Cancer. 1995, 76 : 2193-2201.
105. YONEMURA Y., NOJIMA N., KAJI M., FUJIMURA T., ITOH H., NINOMIYA I., MIYAZAKI I., ENDO Y., SASAKI T. E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinoma. Cancer, 1995, 76 : 941-953.
106. ILYAS M., NOVELLI M., WILKINSON K., TOMLINSON I.P.M., ABBASI A.M., FORBES A., TALBOT I.C. Tumour recurrence is associated with Jass grouping but not with differences in E-cadherin expression in moderately differentiated Dukes' B colorectal cancers. J. Clin. Pathol., 1997, 50 : 218-222.
107. TERRÉS A.M., PAJARES J.M., O'TOOLE D., AHERN S., KELLEHER D. H pylori infection is associated with downregulation of E-cadherin, a molecule involved in epithelial cell adhesion and proliferation control. J. Clin. Pathol., 1998, 51 : 410-412.
108. HIROHASHI S. Inactivatin of the E-cadherin-mediated cell adhesion system in human cancers. Am. J. Pathol., 1998, 153 : 333-339.
109. SPARKS A.B., MORIN P.J., VOGELSTEIN B., KINZLER K.W. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res., 1998, 58 : 1130-1134.
110. MAREEL M., NOË V., VERMEULEN S., BRACKE M. Anti-invasive therapy : manipulation of the E-cadherin/catenin/cytoskeleton complex. Anticancer Drugs, 1996, 7 (Suppl 3) : 149-156.
111. STEIDLER E., ROBINSON K., CHAMBERLAIN L., SCHOFIELD K.M., REMAUT E., LE PAGE R.W.F., WELLS J.M. Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect. Immun., 1998, 66 : 3183-3189.
112. FORBES J.F. The control of breast cancer : the role of tamoxifen. Semin. Oncol., 1997, 24 (Suppl 1): SI-5-SI-19.
113. KIPI. J. Cell Biol., 1998, 142 : 557-571.
114. DIMANCHE-BOITREL M.T., GENNE P., DUCHAMP O., CHAUFFERT B. Confluence dependent resistance (CDR) to doxorubicin and E-cadherin expression in murine mammary cells. Cancer Lett., 1994, 85 : 171-176.
115. FIDLER I.J. The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur. J. Cancer, 1973, 9 : 223-227.